EPA-话题@MedSci

#EPA#

1120篇内容 | 5250人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1427215, encodeId=b919142e2159f, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：肝脏僵硬测量可检测出晚期肝纤维化，并可预测丙型肝炎相关事件, objectType=article, longId=147944, objectId=72a314e94463, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72a314e94463, replyNumber=0, likeNumber=86, createdTime=2018-09-02, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72a314e94463, moduleTitle=J Hepatol：肝脏僵硬测量可检测出晚期肝纤维化，并可预测丙型肝炎相关事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72a314e94463)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427214, encodeId=4304142e214bd, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：3级肥胖是失代偿性肝硬化患者发生慢加急性肝衰竭的危险因素, objectType=article, longId=147942, objectId=c24b14e94268, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c24b14e94268, replyNumber=0, likeNumber=105, createdTime=2018-09-02, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c24b14e94268, moduleTitle=J Hepatol：3级肥胖是失代偿性肝硬化患者发生慢加急性肝衰竭的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c24b14e94268)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427213, encodeId=523f142e21357, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：较低的皮下脂肪组织指数与女性肝硬化患者死亡率较高相关, objectType=article, longId=147939, objectId=0b1414e93974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b1414e93974, replyNumber=0, likeNumber=90, createdTime=2018-09-02, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b1414e93974, moduleTitle=J Hepatol：较低的皮下脂肪组织指数与女性肝硬化患者死亡率较高相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b1414e93974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427212, encodeId=81e9142e212a3, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：联合SSM与Baveno VI标准可能有助于排除代偿性晚期肝硬化患者的高风险静脉曲张, objectType=article, longId=147938, objectId=29c314e93847, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29c314e93847, replyNumber=0, likeNumber=96, createdTime=2018-09-02, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29c314e93847, moduleTitle=J Hepatol：联合SSM与Baveno VI标准可能有助于排除代偿性晚期肝硬化患者的高风险静脉曲张, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29c314e93847)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427211, encodeId=eb24142e211a4, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：巨噬细胞促进小鼠硬化性胆管炎发展, objectType=article, longId=147936, objectId=5d1814e936dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d1814e936dd, replyNumber=0, likeNumber=78, createdTime=2018-09-02, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d1814e936dd, moduleTitle=J Hepatol：巨噬细胞促进小鼠硬化性胆管炎发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d1814e936dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427210, encodeId=4e5a142e21060, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：非硬化群体中患有α-1抗胰蛋白酶缺乏症的成人的临床和组织学特征, objectType=article, longId=147742, objectId=751514e7424a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=751514e7424a, replyNumber=0, likeNumber=88, createdTime=2018-08-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=751514e7424a, moduleTitle=J Hepatol：非硬化群体中患有α-1抗胰蛋白酶缺乏症的成人的临床和组织学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=751514e7424a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427209, encodeId=ca63142e209fc, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：在HCV患者抗病毒治疗后，开发出一种可以患者发生HCC风险的模型, objectType=article, longId=147741, objectId=96b614e7416e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96b614e7416e, replyNumber=0, likeNumber=89, createdTime=2018-08-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96b614e7416e, moduleTitle=J Hepatol：在HCV患者抗病毒治疗后，开发出一种可以患者发生HCC风险的模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96b614e7416e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427208, encodeId=cf57142e20861, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：采用midodrine和白蛋白治疗肝硬化患者，血管收缩系统活性轻微下降，但不能阻碍肝硬化并发症和改善患者生存, objectType=article, longId=147740, objectId=29e114e740fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29e114e740fa, replyNumber=0, likeNumber=130, createdTime=2018-08-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29e114e740fa, moduleTitle=J Hepatol：采用midodrine和白蛋白治疗肝硬化患者，血管收缩系统活性轻微下降，但不能阻碍肝硬化并发症和改善患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29e114e740fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427207, encodeId=eb6c142e2075e, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：评估酒精性肝硬化患者肝细胞癌发病率, objectType=article, longId=147739, objectId=b40914e7396f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b40914e7396f, replyNumber=0, likeNumber=76, createdTime=2018-08-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b40914e7396f, moduleTitle=J Hepatol：评估酒精性肝硬化患者肝细胞癌发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b40914e7396f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427206, encodeId=5b5b142e20633, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：采用Sofosbuvir/velpatasvir治疗HCV基因1-4型肝移植受者, objectType=article, longId=147738, objectId=506414e73818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=506414e73818, replyNumber=0, likeNumber=134, createdTime=2018-08-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=506414e73818, moduleTitle=J Hepatol：采用Sofosbuvir/velpatasvir治疗HCV基因1-4型肝移植受者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=506414e73818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427205, encodeId=fc7e142e205bb, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Gastroenterol Hepatol：包含核心启动子(BCP) A1762T突变的预测肝纤维化的新指标, objectType=article, longId=147542, objectId=1f0214e542ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f0214e542ba, replyNumber=0, likeNumber=131, createdTime=2018-08-29, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f0214e542ba, moduleTitle=J Gastroenterol Hepatol：包含核心启动子(BCP) A1762T突变的预测肝纤维化的新指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f0214e542ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427204, encodeId=0824142e20460, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Gastroenterol Hepatol：胆结石患者小肠细菌过度生长的特点, objectType=article, longId=147541, objectId=f8b814e541cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8b814e541cf, replyNumber=0, likeNumber=151, createdTime=2018-08-29, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8b814e541cf, moduleTitle=J Gastroenterol Hepatol：胆结石患者小肠细菌过度生长的特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8b814e541cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427203, encodeId=7235142e2039d, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Gastroenterol Hepatol：肝细胞癌监测失败的发生率和危险因素, objectType=article, longId=147540, objectId=861514e540d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=861514e540d8, replyNumber=0, likeNumber=183, createdTime=2018-08-29, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=861514e540d8, moduleTitle=J Gastroenterol Hepatol：肝细胞癌监测失败的发生率和危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=861514e540d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427202, encodeId=2a80142e202cf, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet Gastroen Hepatol：SGLT1抑制剂mizagliflozin用于改善功能性便秘, objectType=article, longId=147525, objectId=198b14e52564, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=198b14e52564, replyNumber=0, likeNumber=93, createdTime=2018-08-29, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=198b14e52564, moduleTitle=Lancet Gastroen Hepatol：SGLT1抑制剂mizagliflozin用于改善功能性便秘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=198b14e52564)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427201, encodeId=5761142e20192, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Viral Hepat：丙型肝炎患者的神经精神症状与自身免疫性肝病患者相似但与乙型肝炎患者的神经精神状态不同, objectType=article, longId=147186, objectId=fa3914e18663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa3914e18663, replyNumber=0, likeNumber=119, createdTime=2018-08-23, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa3914e18663, moduleTitle=J Viral Hepat：丙型肝炎患者的神经精神症状与自身免疫性肝病患者相似但与乙型肝炎患者的神经精神状态不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa3914e18663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427200, encodeId=1053142e200e5, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Viral Hepat：全剂量的sofobuvir联合NS5A抑制剂是治疗严重肾功能不全的HCV患者的一种良好的耐受性和有效的治疗方法, objectType=article, longId=147185, objectId=72b714e1854b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72b714e1854b, replyNumber=0, likeNumber=81, createdTime=2018-08-23, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72b714e1854b, moduleTitle=J Viral Hepat：全剂量的sofobuvir联合NS5A抑制剂是治疗严重肾功能不全的HCV患者的一种良好的耐受性和有效的治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72b714e1854b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427199, encodeId=1b5f142e199c1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Viral Hepat：Toll样受体4多态性与印度患者感染戊型肝炎病毒的关系, objectType=article, longId=147184, objectId=a29414e1849a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a29414e1849a, replyNumber=0, likeNumber=91, createdTime=2018-08-23, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a29414e1849a, moduleTitle=J Viral Hepat：Toll样受体4多态性与印度患者感染戊型肝炎病毒的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a29414e1849a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427198, encodeId=09ce142e19805, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet Gastroen Hepatol：轻中度溃疡性结肠炎药物治疗方案效果评估, objectType=article, longId=147068, objectId=990314e06864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=990314e06864, replyNumber=0, likeNumber=241, createdTime=2018-08-22, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=990314e06864, moduleTitle=Lancet Gastroen Hepatol：轻中度溃疡性结肠炎药物治疗方案效果评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=990314e06864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427197, encodeId=c815142e19783, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=LANCET INFEC DIS: Pfs25H-EPA/Alhydrogel传播阻断疫苗的安全性和免疫原性, objectType=article, longId=146610, objectId=622f146610c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=622f146610c5, replyNumber=0, likeNumber=72, createdTime=2018-08-16, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=622f146610c5, moduleTitle=LANCET INFEC DIS: Pfs25H-EPA/Alhydrogel传播阻断疫苗的安全性和免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=622f146610c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427196, encodeId=4cd2142e19628, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Gastroen Hepatol：胃酸抑制剂与肾病风险研究, objectType=article, longId=146550, objectId=e40314655056, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e40314655056, replyNumber=0, likeNumber=82, createdTime=2018-08-15, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e40314655056, moduleTitle=J Gastroen Hepatol：胃酸抑制剂与肾病风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e40314655056)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EPA

2020-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：肝脏僵硬测量可检测出晚期肝纤维化，并可预测丙型肝炎相关事件

2018-09-02

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：3级肥胖是失代偿性肝硬化患者发生慢加急性肝衰竭的危险因素

2018-09-02

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：较低的皮下脂肪组织指数与女性肝硬化患者死亡率较高相关

2018-09-02

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：联合SSM与Baveno VI标准可能有助于排除代偿性晚期肝硬化患者的高风险静脉曲张

2018-09-02

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：巨噬细胞促进小鼠硬化性胆管炎发展

2018-09-02

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：非硬化群体中患有α-1抗胰蛋白酶缺乏症的成人的临床和组织学特征

2018-08-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：在HCV患者抗病毒治疗后，开发出一种可以患者发生HCC风险的模型

2018-08-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：采用midodrine和白蛋白治疗肝硬化患者，血管收缩系统活性轻微下降，但不能阻碍肝硬化并发症和改善患者生存

2018-08-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：评估酒精性肝硬化患者肝细胞癌发病率

2018-08-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：采用Sofosbuvir/velpatasvir治疗HCV基因1-4型肝移植受者

2018-08-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Gastroenterol Hepatol：包含核心启动子(BCP) A1762T突变的预测肝纤维化的新指标

2018-08-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Gastroenterol Hepatol：胆结石患者小肠细菌过度生长的特点

2018-08-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Gastroenterol Hepatol：肝细胞癌监测失败的发生率和危险因素

2018-08-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet Gastroen Hepatol：SGLT1抑制剂mizagliflozin用于改善功能性便秘

2018-08-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Viral Hepat：丙型肝炎患者的神经精神症状与自身免疫性肝病患者相似但与乙型肝炎患者的神经精神状态不同

2018-08-23

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Viral Hepat：全剂量的sofobuvir联合NS5A抑制剂是治疗严重肾功能不全的HCV患者的一种良好的耐受性和有效的治疗方法

2018-08-23

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Viral Hepat：Toll样受体4多态性与印度患者感染戊型肝炎病毒的关系

2018-08-23

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet Gastroen Hepatol：轻中度溃疡性结肠炎药物治疗方案效果评估

2018-08-22

gwc384 (审核中...)

前往app查看评论内容

#EPA#

LANCET INFEC DIS: Pfs25H-EPA/Alhydrogel传播阻断疫苗的安全性和免疫原性

2018-08-16

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Gastroen Hepatol：胃酸抑制剂与肾病风险研究

2018-08-15

科室
- - 订阅+
  - 更多科室
工具
服务